The Enterprise Value as of December 2024 (TTM) for IO Biotech, Inc. (IOBT) is -18214372.00

According to IO Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -18214372.00. This represents a change of 35.79% compared to the average of -13413483.84 of the last 4 quarters.

IO Biotech, Inc. (IOBT) Historical Enterprise Value (quarterly & annually)

How has IOBT Enterprise Value performed in the past?

The mean historical Enterprise Value of IO Biotech, Inc. over the last ten years is 147.97M. The current -18214372.00 Enterprise Value has changed -1330.96% with respect to the historical average. Over the past ten years (40 quarters), IOBT's Enterprise Value was at its highest in in the September 2021 quarter at 385.43M. The Enterprise Value was at its lowest in in the September 2023 quarter at -92160692.77.

IO Biotech, Inc. (IOBT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IO Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IO Biotech, Inc. (IOBT) Average Enterprise Value

How has IOBT Enterprise Value performed in the past?

The current Enterprise Value of IO Biotech, Inc. (IOBT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IO Biotech, Inc. (IOBT) Enterprise Value vs. Peers

How is IOBT’s Enterprise Value compared to its peers?

IO Biotech, Inc.’s Enterprise Value is less than PMV Pharmaceuticals, Inc. (40.53M), less than Eliem Therapeutics, Inc. (0), less than MediciNova, Inc. (59.45M), less than Pharvaris N.V. (672.48M), less than PepGen Inc. (108.11M), less than Pardes Biosciences, Inc. (75.90M), less than Shattuck Labs, Inc. (12.78M), less than Champions Oncology, Inc. (112.78M), less than Century Therapeutics, Inc. (89.16M), less than Structure Therapeutics Inc. (1.45B), less than Erasca, Inc. (710.66M), less than ASLAN Pharmaceuticals Limited (9.97M), less than Lyra Therapeutics, Inc. (22.80M), less than Monte Rosa Therapeutics, Inc. (351.25M), less than NewAmsterdam Pharma Company N.V. (2.35B), less than Inventiva S.A. (222.87M), less than Cullinan Oncology, Inc. (614.81M), less than Compass Therapeutics, Inc. (176.46M), less than Design Therapeutics, Inc. (331.74M), less than Werewolf Therapeutics, Inc. (-17421672.00), less than Ikena Oncology, Inc. (37.04M), less than Stoke Therapeutics, Inc. (451.87M),

Build a custom stock screener for IO Biotech, Inc. (IOBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IO Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IO Biotech, Inc. (IOBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IO Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.